Drugs / JW0202
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06361277 | Nov 2023 | — | JW Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JW0202 | “Reference Drug(C2205 and JW0201) or Test Drug(JW0202 and C2202)” NCT06361277 ↗ |